Task: Answer the multiple-choice question.
Question: Which drug exhibits a -20.189% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] Cc1ccccc1CNC(=O)c1cc2ccccc2o1
[b] Cc1ccc(S(=O)(=O)N(C)CC(=O)OCc2nnc(-c3ccccc3)o2)cc1
[c] O=C(CSc1nc2ccccc2s1)Nc1cc(S(=O)(=O)N2CCOCC2)ccc1O
[d] O=C(NCCCO)C(=O)NCC1OCCCN1S(=O)(=O)c1cccs1
[e] COc1ccc(CCN(C)C2CCCN(S(=O)(=O)C(C)C)C2)cc1OC
Answer: e. COc1ccc(CCN(C)C2CCCN(S(=O)(=O)C(C)C)C2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCN(C)C2CCCN(S(=O)(=O)C(C)C)C2)cc1OC
COc1ccc(CCN(C)C2CCCN(S(=O)(=O)C(C)C)C2)cc1OC
N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methyl-1-propan-2-ylsulfonylpiperidin-3-amine